Signet Innovations was formed in 2014 as Jeff Spitzner partnered with leading private equity company Signet Enterprises (now Signet, LLC) to launch an early form of a Venture Studio. The mission was to enable the investors and the expertise and team they brought to form the companies directly and efficiently rather the come in later at a more expensive price. Signet Innovations focused on licensing and commercializing technology and IP from universities and research institutions to create new companies and bring new products to market. Signet Accel was the premiere company in the Innovations portfolio. Signet Innovations was building an active portfolio in strategic sectors and looks for technologies and early-stage companies with substantial growth opportunities and synergies within its portfolio.
Verticals of interest include healthcare/life sciences IT (software), healthcare technologies, energy, materials, engineering, and life sciences.
Innovations is a Signet Enterprises company. The Signet parent is a private equity company that currently has over $4 Billion of active projects, ranging from real estate development for health and education systems to a diverse portfolio of over 25 companies that were acquired by Signet, to Integrated Wellness partners and Signet Accel.
My role was to co-found the Innovations venture studio concept, and then to find great opportunities, lead the due diligence efforts, perform business development activities, and build bridges between business and technology in order to develop business plans that enable creation of exceptional companies. I served as Director and Chief Science Officer of Signet Innovations.